Author

Clarisse Mouriaux

Établissement Français du SangORCID 0000-0002-0817-7818Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Cristina LiboniiD· 2 shared Jacky G. GoetziD· 2 shared Louis BochleriD· 2 shared María Jesús García-LeóniD· 2 shared Olivier LefèbvreiD· 2 shared Pierre ManginiD· 2 shared Vincent MittelheisseriD· 2 shared Alexandra A. YakushevaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Cristina LiboniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyiSciencePeer-reviewedJul 31, 2025

Depletion of all platelet integrins impacts hemostasis, thrombosis and tumor metastasis

Emily Janus‐Bell, Cristina Liboni, Alexandra A. Yakusheva…·Pierre Mangin

This study shows that depleting all platelet integrins in mice increases bleeding time, impairs arterial thrombosis, and reduces tumor growth and metastasis.

2 citations

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 9, 2025

Tumoral CD24 tunes platelets binding and pro-metastatic functions

Vincent Mittelheisser, Cristina Liboni, Clarisse Mouriaux…·Jacky G. Goetz

This study identifies CD24 as a regulator of tumor cell-platelet interactions that enhance metastatic potential and suggests it as a druggable target.

DOI 10.1101/2025.04.09.648049

humanbulk RNA-seq

𝕏 PostBluesky